Best Medical Stocks To Watch Today - July 23rd

Hims & Hers Health, Thermo Fisher Scientific, UnitedHealth Group, Abivax, Intuitive Surgical, Eli Lilly and Company, and Boston Scientific are the seven Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies operating in the healthcare sector—including pharmaceutical firms, biotechnology developers, medical device manufacturers, and healthcare service providers. Investors buy these stocks to gain exposure to the sector’s growth potential, which is driven by drug approvals, technological innovations, and demographic trends, while also accepting risks from regulatory hurdles, clinical-trial outcomes, and competitive pressures. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Hims & Hers Health (HIMS)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Shares of HIMS stock traded up $6.79 during mid-day trading on Wednesday, hitting $56.80. 49,818,315 shares of the stock traded hands, compared to its average volume of 24,390,236. The firm has a market cap of $12.71 billion, a price-to-earnings ratio of 82.32, a price-to-earnings-growth ratio of 1.76 and a beta of 2.02. The company's 50-day simple moving average is $53.82 and its 200-day simple moving average is $42.04. Hims & Hers Health has a twelve month low of $13.47 and a twelve month high of $72.98.

Read Our Latest Research Report on HIMS

Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

Shares of NYSE TMO traded up $48.60 during mid-day trading on Wednesday, reaching $476.22. The company had a trading volume of 5,885,563 shares, compared to its average volume of 2,450,044. Thermo Fisher Scientific has a 1-year low of $385.46 and a 1-year high of $627.88. The company has a current ratio of 1.77, a quick ratio of 1.38 and a debt-to-equity ratio of 0.64. The stock has a market cap of $179.77 billion, a PE ratio of 27.93, a P/E/G ratio of 1.96 and a beta of 0.77. The company has a 50-day moving average price of $410.38 and a two-hundred day moving average price of $472.32.

Read Our Latest Research Report on TMO

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Shares of UNH stock traded up $3.66 on Wednesday, reaching $288.79. 7,302,956 shares of the company's stock traded hands, compared to its average volume of 11,190,314. The company has a market capitalization of $261.97 billion, a P/E ratio of 12.09, a price-to-earnings-growth ratio of 1.38 and a beta of 0.45. UnitedHealth Group has a 12-month low of $248.88 and a 12-month high of $630.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The business's 50 day moving average price is $304.47 and its two-hundred day moving average price is $432.39.

Read Our Latest Research Report on UNH

Abivax (ABVX)

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults.

Shares of NASDAQ:ABVX traded up $55.64 on Wednesday, reaching $65.64. The company had a trading volume of 23,125,519 shares, compared to its average volume of 312,350. Abivax has a twelve month low of $4.77 and a twelve month high of $69.24. The stock has a 50-day moving average price of $7.14 and a 200 day moving average price of $6.80. The company has a debt-to-equity ratio of 1.29, a current ratio of 1.25 and a quick ratio of 1.25.

Read Our Latest Research Report on ABVX

Intuitive Surgical (ISRG)

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Shares of NASDAQ ISRG traded down $14.78 during trading hours on Wednesday, hitting $496.22. 2,638,524 shares of the company's stock were exchanged, compared to its average volume of 1,670,153. Intuitive Surgical has a 1-year low of $425.00 and a 1-year high of $616.00. The stock has a market capitalization of $177.85 billion, a price-to-earnings ratio of 72.42, a PEG ratio of 5.47 and a beta of 1.64. The company's 50-day moving average price is $535.90 and its 200-day moving average price is $536.29.

Read Our Latest Research Report on ISRG

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

LLY traded up $21.20 on Wednesday, hitting $797.64. 1,389,739 shares of the stock traded hands, compared to its average volume of 3,771,169. Eli Lilly and Company has a 52 week low of $677.09 and a 52 week high of $972.53. The firm has a market capitalization of $755.95 billion, a PE ratio of 64.90, a P/E/G ratio of 1.10 and a beta of 0.40. The business has a fifty day moving average price of $767.03 and a two-hundred day moving average price of $800.17. The company has a current ratio of 1.37, a quick ratio of 1.06 and a debt-to-equity ratio of 2.18.

Read Our Latest Research Report on LLY

Boston Scientific (BSX)

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system.

Shares of BSX traded up $3.88 on Wednesday, hitting $107.04. The company's stock had a trading volume of 9,691,023 shares, compared to its average volume of 7,699,468. The company has a 50 day moving average price of $103.42 and a 200 day moving average price of $101.16. Boston Scientific has a fifty-two week low of $71.88 and a fifty-two week high of $108.94. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.45 and a quick ratio of 0.88. The company has a market capitalization of $158.36 billion, a PE ratio of 78.13, a PEG ratio of 3.02 and a beta of 0.68.

Read Our Latest Research Report on BSX

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.